首页>
外国专利>
Combination therapy of type II anti-CD20 antibody and proteasome inhibitor
Combination therapy of type II anti-CD20 antibody and proteasome inhibitor
展开▼
机译:II型抗CD20抗体和蛋白酶体抑制剂的联合治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a proteasome inhibitor for the treatment of a patient suffering from cancer, particularly a CD20-expressing cancer. An aspect of the invention is a composition comprising a type II anti-CD20 antibody and a proteasome inhibitor. Another aspect of the invention is a kit comprising a type II anti-CD20 antibody and a proteasome inhibitor. Yet another aspect of the invention is a method for the treatment of a patient suffering from cancer comprising co-administering, to a patient in need of such treatment, a type II anti-CD20 antibody and a proteasome inhibitor.
展开▼